Skip to main content
. 2020 Dec 30;18(12):e3001017. doi: 10.1371/journal.pbio.3001017

Table 2. Comparison of SCAN-seq to current TGS base scRNA-seq methods.

Method Amplification Sequencing platform No. of cells in a library Cell capture efficiency No. of UMIs per cell No. of full-length genes per cell Experiment cost per cell
SCAN-seq Smart-seq2 Nanopore 10–48 80% 8,000 US$3
R2C2 [2728] Smart-seq2 Nanopore 1–96 64% 532 US$7
ScISOr-Seq [24] 10x Genomics NGS+Pacbio >5,000 40% 260 129 US$0.3
ScNaUmi-seq [25] 10x Genomics NGS+Nanopore 100–1,000 40% 6047 2,427 US$5
RAGE-seq [26] 10x Genomics NGS+Nanopore 2,500–6,000 18.7% TCR/BCR mRNA US$0.5

BCR, B cell receptor; NGS, next generation sequencing; RAGE-seq, Repertoire and Gene Expression by Sequencing; R2C2, Rolling Circle Amplification to Concatemeric Consensus; SCAN-seq, single cell amplification and sequencing of full-length RNAs by Nanopore platform; ScISOr-Seq, single-cell isoform RNA-Seq; ScNaUmi-seq, Single-cell Nanopore sequencing with UMIs; scRNA-seq, single-cell RNA sequencing; TCR, T cell receptor; TGS, third-generation sequencing; UMI, unique molecular identifier.